A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

City of Hope Medical Center

ClinicalTrials.gov Identifier:

NCT01172964

First received: July 28, 2010

Last updated: March 6, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2014 (Final data collection date for primary outcome measure)